Amber D. Steele

Array ( [id] => 4846491 [patent_doc_number] => 20080182899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'ASSOCIATION OF BETA3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/050557 [patent_app_country] => US [patent_app_date] => 2008-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3185 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182899.pdf [firstpage_image] =>[orig_patent_app_number] => 12050557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682927 [patent_doc_number] => 20080249153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'ANTHELMINTIC FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/049039 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7628 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249153.pdf [firstpage_image] =>[orig_patent_app_number] => 12049039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820706 [patent_doc_number] => 20080226715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'THERAPEUTIC COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/049223 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15657 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226715.pdf [firstpage_image] =>[orig_patent_app_number] => 12049223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432332 [patent_doc_number] => 20100152201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Oligomer-Antihistamine Conjugates' [patent_app_type] => utility [patent_app_number] => 12/530393 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22028 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152201.pdf [firstpage_image] =>[orig_patent_app_number] => 12530393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887760 [patent_doc_number] => 20080262092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'REGULATION OF OSTEOPONTIN' [patent_app_type] => utility [patent_app_number] => 12/045623 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11304 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262092.pdf [firstpage_image] =>[orig_patent_app_number] => 12045623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4699041 [patent_doc_number] => 20080221225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Genes associated with restenosis' [patent_app_type] => utility [patent_app_number] => 12/074964 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15087 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221225.pdf [firstpage_image] =>[orig_patent_app_number] => 12074964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386438 [patent_doc_number] => 20090227683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Compositions for Providing an Analgesic Effect to the Skin' [patent_app_type] => utility [patent_app_number] => 12/043373 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4521 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227683.pdf [firstpage_image] =>[orig_patent_app_number] => 12043373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728025 [patent_doc_number] => 20080207569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Methods for the treatment of liver diseases' [patent_app_type] => utility [patent_app_number] => 12/072849 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20150 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207569.pdf [firstpage_image] =>[orig_patent_app_number] => 12072849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728061 [patent_doc_number] => 20080207605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Combination therapy for the treatment of liver diseases' [patent_app_type] => utility [patent_app_number] => 12/072729 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20517 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207605.pdf [firstpage_image] =>[orig_patent_app_number] => 12072729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518919 [patent_doc_number] => 20100216992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'MIMETIC COMPOSITIONS AND THE PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/528689 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24359 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216992.pdf [firstpage_image] =>[orig_patent_app_number] => 12528689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728215 [patent_doc_number] => 20080207759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'METHOD FOR PROTECTING MITOCHONDRIA' [patent_app_type] => utility [patent_app_number] => 12/037435 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6613 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207759.pdf [firstpage_image] =>[orig_patent_app_number] => 12037435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590066 [patent_doc_number] => 20100130452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Use of Doxycycline in the Treatment of Idiopathic Pulmonary Fibrosis' [patent_app_type] => utility [patent_app_number] => 12/528225 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1937 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130452.pdf [firstpage_image] =>[orig_patent_app_number] => 12528225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328567 [patent_doc_number] => 20100197788 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-08-05 [patent_title] => 'Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid' [patent_app_type] => utility [patent_app_number] => 12/070495 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7416 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0197/20100197788.pdf [firstpage_image] =>[orig_patent_app_number] => 12070495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296369 [patent_doc_number] => 20100240638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Organic Compounds and their uses' [patent_app_type] => utility [patent_app_number] => 12/527787 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78721 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240638.pdf [firstpage_image] =>[orig_patent_app_number] => 12527787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328567 [patent_doc_number] => 20100197788 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-08-05 [patent_title] => 'Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid' [patent_app_type] => utility [patent_app_number] => 12/070495 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7416 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0197/20100197788.pdf [firstpage_image] =>[orig_patent_app_number] => 12070495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417018 [patent_doc_number] => 20090042905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'TRIAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/031089 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 61696 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042905.pdf [firstpage_image] =>[orig_patent_app_number] => 12031089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53274 [patent_doc_number] => 07772222 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same' [patent_app_type] => utility [patent_app_number] => 12/028152 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 16692 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772222.pdf [firstpage_image] =>[orig_patent_app_number] => 12028152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 54064 [patent_doc_number] => 07767661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Diarylalkanes as potent inhibitors of binuclear enzymes' [patent_app_type] => utility [patent_app_number] => 12/027090 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17051 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767661.pdf [firstpage_image] =>[orig_patent_app_number] => 12027090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955440 [patent_doc_number] => 20080188464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Combinations of Dopamine D2 Receptor Blockade with Norepinephrine Reuptake Inhibition and With Norepinephrine Alpha 2 Receptor Blockade' [patent_app_type] => utility [patent_app_number] => 12/024950 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 2700 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188464.pdf [firstpage_image] =>[orig_patent_app_number] => 12024950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955433 [patent_doc_number] => 20080188457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Modulation of Neurogenesis with Biguanides and GSK3-beta Agents' [patent_app_type] => utility [patent_app_number] => 12/024923 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 42103 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188457.pdf [firstpage_image] =>[orig_patent_app_number] => 12024923 [rel_patent_id] =>[rel_patent_doc_number] =>)